Hello,
We recently had a production failure caused by the issue fixed in r53624 on the trunk [1]. I see that this patch has also been applied to py3k-struni. Should this patch be merged to the release branches? In the meantime we will have to patch subprocess.py ourselves.
[1] http://mail.python.org/pipermail/python-checkins/2007-February/058421.html
Thanks,
-- Aaron Bingham Senior Software Engineer bingham@cenix-bioscience.com Tel. +49 (0)351 4173-146 Fax +49 (0)351 4173-109
Cenix BioScience GmbH Tatzberg 47 01307 Dresden, Germany www.cenix-bioscience.com
Sitz der Gesellschaft (Place of Business): Dresden Geschäftsführer (CEO): Dr. Christophe J. Echeverri Amtsgericht (Local Court): Dresden, HRB 19964
WICHTIGE INFORMATION: Diese Email, inklusive der Anhänge, ist ausschließlich für den Gebrauch durch die hierzu berechtigten Empfänger bestimmt. Sollten Sie nicht der für diese Email bestimmte Adressat sein, ist Ihnen jede Veröffentlichung, Vervielfältigung oder Weitergabe dieses Dokuments untersagt. Bitte senden Sie eine Email an info@cenix-bioscience.com, falls Sie diese Email versehentlich erhalten haben. Vielen Dank!
IMPORTANT NOTICE: This message, including any attached documents, is intended only for the use of the individual or entity to which it is addressed, and may contain information that is privileged, confidential and exempt from disclosure under applicable law. If the reader of this Message is not the intended recipient, or the employee or agent responsible for delivering the message to the intended recipient, you are hereby notified that any dissemination, distribution or copying of this communication is strictly prohibited. If you have received this communication in error, please notify Cenix BioScience immediately by email at info@cenix-bioscience.com. Thank you.
Aaron> We recently had a production failure caused by the issue fixed in
Aaron> r53624 on the trunk [1]. I see that this patch has also been
Aaron> applied to py3k-struni. Should this patch be merged to the
Aaron> release branches? In the meantime we will have to patch
Aaron> subprocess.py ourselves.
In theory, I'm in favor of backporting, but how far back do you need/want to apply it? There will clearly be more 2.5 releases. I don't think any more 2.4 releases are planned.
Skip
skip@pobox.com wrote:
Aaron> We recently had a production
failure caused by the issue fixed in
Aaron> r53624 on the trunk [1]. I see that this patch has also been
Aaron> applied to py3k-struni. Should this patch be merged to the
Aaron> release branches? In the meantime we will have to patch
Aaron> subprocess.py ourselves.
In theory, I'm in favor of backporting, but how far back do you need/want to
apply it? There will clearly be more 2.5 releases. I don't think any more
2.4 releases are planned.
We will only be supporting 2.4 for a few months more, so as far as we
are concerned a backport to 2.5 would be sufficient.
Thanks,
-- Aaron Bingham Senior Software Engineer bingham@cenix-bioscience.com Tel. +49 (0)351 4173-146 Fax +49 (0)351 4173-109
Cenix BioScience GmbH Tatzberg 47 01307 Dresden, Germany www.cenix-bioscience.com
Sitz der Gesellschaft (Place of Business): Dresden Geschäftsführer (CEO): Dr. Christophe J. Echeverri Amtsgericht (Local Court): Dresden, HRB 19964
WICHTIGE INFORMATION: Diese Email, inklusive der Anhänge, ist ausschließlich für den Gebrauch durch die hierzu berechtigten Empfänger bestimmt. Sollten Sie nicht der für diese Email bestimmte Adressat sein, ist Ihnen jede Veröffentlichung, Vervielfältigung oder Weitergabe dieses Dokuments untersagt. Bitte senden Sie eine Email an info@cenix-bioscience.com, falls Sie diese Email versehentlich erhalten haben. Vielen Dank!
IMPORTANT NOTICE: This message, including any attached documents, is intended only for the use of the individual or entity to which it is addressed, and may contain information that is privileged, confidential and exempt from disclosure under applicable law. If the reader of this Message is not the intended recipient, or the employee or agent responsible for delivering the message to the intended recipient, you are hereby notified that any dissemination, distribution or copying of this communication is strictly prohibited. If you have received this communication in error, please notify Cenix BioScience immediately by email at info@cenix-bioscience.com. Thank you.